Shorter courses of radiation therapy for early-stage prostate cancer has potential to change practice
16:53 Share

Howard Sandler, MD, MS, FASTRO, FASCO, and Scott Morgan, MD, MSc, FRCPC, discuss moderate hypofractionation and how men with early-stage prostate cancer can benefit. Sandler and Morgan are co-chairs of the panel that authored Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.